Over the past decade, the involvement of tyrosine kinases in signal transdu
ction pathways evoked by cytokines has been intensively investigated. Only
relatively recently have the roles of serine/threonine kinases in cytokine-
induced signal transduction and anti-apoptotic pathways been examined. Cyto
kine receptors without intrinsic kinase activity such as interleukin-3 (IL-
3), granulocyte-macrophage colony-stimulating factor (GM-CSF) and the inter
ferons were thought to transmit their regulatory signals primarily by the r
eceptor-associated Jak family of tyrosine kinases. This family of tyrosine
kinases activates STAT transcription factors, which subsequently transduced
their signals into the nucleus to modulate gene expression. Cytokine recep
tors with intrinsic tyrosine kinase activity such as c-Kit were initially t
hought to transduce their signals independently of serine/threonine kinase
cascades. Recently, both of these types of receptor signaling pathways have
been shown to interact with serine/threonine kinase pathways as maximal ac
tivation of these tyrosine kinase regulated cascades involve serine/threonl
ne phosphorylation modulated by, for example MAP kinases. A common intermed
iate pathway initiating from cytokine receptors is the Ras/Raf/MEK/ERK (MAP
K) cascade, which can result in the phosphorylation and activation of addit
ional downstream kinases and transcription factors such as p90(Rsk), ORES,
Elk and Egr-1. Serine/threonine phosphorylation is also involved in the reg
ulation of the apoptosis-controlling Bcl-2 protein, as certain phosphorylat
ion events induced by cytokines such as IL-3 are anti-apoptotic, whereas ot
her phosphorylation events triggered by chemotherapeutic drugs such as Pacl
itaxel are associated with cell death. Serine/threonine phosphorylation is
implicated in the etiology of certain human cancers as constitutive serine
phosphorylation of STATs 1 and 3 is observed in chronic lymphocytic leukemi
a and can be inhibited by the chemotherapeutic drug fludarabine, Serine/thr
eonine phosphorylation also plays a role in the etiology of immunodeficienc
ies. Activated STAT5 proteins are detected in reduced levels in lymphocytes
recovered from HIV-infected individuals and immunocompromised mice. Serine
/threonine phosphorylation may be an important target of certain chemothera
peutic drugs which recognize the activated proteins. This meeting report an
d mini-review will discuss the interactions of serine/threonine kinases wit
h signal transduction and apoptotic molecules and how some of these pathway
s can be controlled by chemotherapeutic drugs.